Cosmo Pharmaceuticals NV (CMOPF)

110.21 +7.56 (+7.36%) USD  |  OTCM  |  Apr 01, 16:00
More

Cosmo Pharmaceuticals EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for CMOPF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Amarin Corp. Plc Upgrade
Jazz Pharmaceuticals Plc Upgrade
Prothena Corp. Plc Upgrade
Iterum Therapeutics Plc Upgrade
GH Research Plc Upgrade